Winner Medical Co., Ltd. (300888.SZ)
CNY 44.8
(2.21%)
CNY 44.8
(2.21%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 3.58 Billion CNY | -34.53% |
| 2022 | 5.37 Billion CNY | 34.16% |
| 2021 | 4 Billion CNY | -46.28% |
| 2020 | 7.46 Billion CNY | 215.89% |
| 2019 | 2.36 Billion CNY | 25.19% |
| 2018 | 1.88 Billion CNY | 12.95% |
| 2017 | 1.67 Billion CNY | 34.01% |
| 2016 | 1.24 Billion CNY | 62.67% |
| 2015 | 766.46 Million CNY | 47.53% |
| 2014 | 519.54 Million CNY | 35.21% |
| 2013 | 384.26 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 892.82 Million CNY | 3.69% |
| 2024 Q3 | 941.86 Million CNY | 3.05% |
| 2024 Q2 | 928.74 Million CNY | 4.02% |
| 2023 Q1 | 1.19 Billion CNY | -30.31% |
| 2023 Q4 | 861.09 Million CNY | 5.0% |
| 2023 FY | 3.52 Billion CNY | -34.53% |
| 2023 Q3 | 820.07 Million CNY | -17.72% |
| 2023 Q2 | 996.63 Million CNY | -16.86% |
| 2022 Q4 | 1.72 Billion CNY | 50.75% |
| 2022 Q3 | 1.14 Billion CNY | -18.96% |
| 2022 Q2 | 1.4 Billion CNY | 26.9% |
| 2022 Q1 | 1.1 Billion CNY | -3.92% |
| 2022 FY | 5.37 Billion CNY | 34.16% |
| 2021 FY | 4 Billion CNY | -46.28% |
| 2021 Q3 | 716.34 Million CNY | -20.19% |
| 2021 Q4 | 1.15 Billion CNY | 61.2% |
| 2021 Q1 | 1.24 Billion CNY | -16.9% |
| 2021 Q2 | 897.58 Million CNY | -27.64% |
| 2020 Q2 | 1.58 Billion CNY | 92.19% |
| 2020 FY | 7.46 Billion CNY | 215.89% |
| 2020 Q1 | 825.5 Million CNY | 17.67% |
| 2020 Q3 | 3.55 Billion CNY | 124.31% |
| 2020 Q4 | 1.49 Billion CNY | -58.05% |
| 2019 Q4 | 701.53 Million CNY | 16.33% |
| 2019 FY | 2.36 Billion CNY | 25.19% |
| 2019 Q3 | 603.05 Million CNY | 15.15% |
| 2019 Q2 | 523.73 Million CNY | 0.0% |
| 2019 Q1 | 523.73 Million CNY | 0.0% |
| 2018 FY | 1.88 Billion CNY | 12.95% |
| 2017 FY | 1.67 Billion CNY | 34.01% |
| 2016 FY | 1.24 Billion CNY | 62.67% |
| 2015 FY | 766.46 Million CNY | 47.53% |
| 2014 FY | 519.54 Million CNY | 35.21% |
| 2013 FY | 384.26 Million CNY | 0.0% |